Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05546255
What this trial is testing

Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00721630
What this trial is testing

Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02236000
What this trial is testing

A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 49
Testing effectiveness (Phase 2)Looking for participantsNCT06238921
What this trial is testing

Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases

Who this might be right for
Breast CancerTriple Negative Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 31
Early research (Phase 1)Study completedNCT01003158
What this trial is testing

Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.

Who this might be right for
NeoplasmsMetastatic CancerBreast Cancer
AstraZeneca 17
Testing effectiveness (Phase 2)Ended earlyNCT01416558
What this trial is testing

Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany)

Who this might be right for
Metastatic Breast Cancer
GBG Forschungs GmbH 66
Large-scale testing (Phase 3)Study completedNCT04085276
What this trial is testing

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

Who this might be right for
Triple-Negative Breast Cancer
Shanghai Junshi Bioscience Co., Ltd. 531
Testing effectiveness (Phase 2)Active Not RecruitingNCT02734290
What this trial is testing

Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Providence Health & Services 29
Testing effectiveness (Phase 2)Study completedNCT01216033
What this trial is testing

Exploratory Study of Breast Cancer With ABY025

Who this might be right for
Breast Cancer
Biomedical Radiation Sciences 7
Testing effectiveness (Phase 2)Study completedNCT02052778
What this trial is testing

TAS-120 in Patients With Advanced Solid Tumors

Who this might be right for
CholangiocarcinomaUrothelial CancerAdvanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors+3 more
Taiho Oncology, Inc. 407
Testing effectiveness (Phase 2)Study completedNCT00034489
What this trial is testing

A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.

Who this might be right for
Breast Neoplasms
Eli Lilly and Company
Early research (Phase 1)Study completedNCT00079625
What this trial is testing

Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 22
Not applicableLooking for participantsNCT06726889
What this trial is testing

Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer
European Institute of Oncology 104
Large-scale testing (Phase 3)Not Yet RecruitingNCT04736589
What this trial is testing

Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway

Who this might be right for
Breast Cancer
Peking Union Medical College 270
Testing effectiveness (Phase 2)UnknownNCT00027989
What this trial is testing

Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Pharmatech Oncology
Testing effectiveness (Phase 2)Ended earlyNCT01290718
What this trial is testing

Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 4
Testing effectiveness (Phase 2)Study completedNCT00031876
What this trial is testing

Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Swiss Cancer Institute 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT02752685
What this trial is testing

Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
NYU Langone Health 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02311933
What this trial is testing

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 81
Testing effectiveness (Phase 2)Ended earlyNCT01534455
What this trial is testing

Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)

Who this might be right for
Metastatic Breast Cancer
GBG Forschungs GmbH 43
Next Page